≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other/unspecified disorders of vestibular function

DOID EFO Endpoint Browser PheWeb

H8_VESTIFUNCNAS

vestibular disease: Pathological processes of the vestibular labyrinth which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls. [database_cross_reference: MESH:D015837]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H81.8, H81.9
  • Hospital discharge: ICD-9 — 386[8-9]
  • Cause of death: ICD-10 — H81.8, H81.9
  • Cause of death: ICD-9 — 386[8-9]

2 out of 7 registries used, show all original rules.

1394

4. Check minimum number of events

None

1394

5. Include endpoints

None

1394

6. Filter based on genotype QC (FinnGen only)

1394

Control definitions (FinnGen only)

Control exclude
H8_INNER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 10780 6802 3882
Only index persons 9261 5920 3341
Unadjusted period prevalence (%)
Whole population 0.16 0.19 0.11
Only index persons 0.19 0.22 0.13
Median age at first event (years)
Whole population 64.51 66.08 61.73
Only index persons 62.36 63.66 60.06

-FinnGen-

Key figures

All Female Male
Number of individuals 1394 882 512
Unadjusted period prevalence (%) 0.27 0.30 0.23
Median age at first event (years) 60.88 60.30 61.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1220
Matched controls
12200
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
1432.0
323.0
845
19
R42
ICD-10 Finland
Dizziness and giddiness
8.8
247.2
696
1604
H81.8
ICD-10 Finland
Other disorders of vestibular function
1315.9
229.8
217
*
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
12.4
153.3
295
305
H81.0
ICD-10 Finland
Ménière disease
123.4
133.3
142
13
3868X
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Other disorders of labyrinth
+∞
116.5
110
*
N07CA01
ATC
betahistine; oral
8.3
111.0
269
404
H81.2
ICD-10 Finland
Vestibular neuronitis
224.7
101.1
103
5
H81.3
ICD-10 Finland
Other peripheral vertigo
34.7
82.8
108
34
AA1AD
NOMESCO Finland
CT of head and brain
3.5
76.8
478
1906
3869X
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Unspecified vertiginous syndromes and labyrinthine disorders
+∞
64.1
61
*
N17
ICPC
Vertigo/dizziness
4.1
59.6
264
769
DFF00
NOMESCO Finland
Pure tone audiometry
4.4
52.1
206
533
DFF59
NOMESCO Finland
Other assessment of balance
32.0
46.2
61
20
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.2
41.6
252
920
G44.2
ICD-10 Finland
Tension-type headache
2.9
32.1
214
822
UDC00
NOMESCO Finland
Ear microscopy
3.6
28.5
135
402
R53
ICD-10 Finland
Malaise and fatigue
2.2
25.8
306
1591
R51.80
ICD-10 Finland
Headache
2.5
24.6
211
929
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
4.8
23.7
81
178
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
53.0
22.1
26
5
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
7.3
21.2
51
72
A02BC02
ATC
pantoprazole; systemic
1.8
20.1
801
6306
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.2
20.1
243
1260
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
20.0
366
2235
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
19.8
556
3919
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
19.4
433
2828
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.8
18.1
119
447
H81.4
ICD-10 Finland
Vertigo of central origin
21.2
17.3
25
12
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
16.9
230
1243
M79.6
ICD-10 Finland
Pain in limb
1.7
16.8
435
2945
R11
ICD-10 Finland
Nausea and vomiting
2.7
16.7
121
481
N05AB04
ATC
prochlorperazine; systemic, rectal
4.5
16.6
59
136
R07.3
ICD-10 Finland
Other chest pain
2.5
16.0
132
566
N02BE01
ATC
paracetamol; systemic, rectal
1.9
15.8
1045
9220
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
15.6
213
1152
DFF50
NOMESCO Finland
Electronystagmography
162.0
15.5
16
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
15.2
358
2340
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.2
15.0
158
762
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
14.8
266
1592
M79.1
ICD-10 Finland
Myalgia
2.2
14.7
161
791
N03AX12
ATC
gabapentin; oral
2.0
14.7
201
1086
H82
ICPC
Vertiginous syndrome
6.2
14.6
39
65
B01AC04
ATC
clopidogrel; oral
2.0
14.2
212
1182
R06.0
ICD-10 Finland
Dyspnoea
1.7
13.7
316
2042
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
4.9
13.2
43
91
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
7.7
13.2
30
40
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
13.1
757
6206
S06.0
ICD-10 Finland
Concussion
2.2
12.9
131
622
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
12.8
435
3124
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
6.1
12.8
34
57
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.3
12.6
123
573
H02AB06
ATC
prednisolone; systemic
1.6
12.5
544
4140
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
12.4
95
391
M03BX02
ATC
tizanidine; oral
1.5
12.3
685
5525
N03AX16
ATC
pregabalin; oral
1.7
12.2
282
1817
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
11.9
254
1591
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
11.9
208
1223
C07AB07
ATC
bisoprolol; oral
1.5
11.9
590
4615
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
11.9
191
1092
R55
ICD-10 Finland
Syncope and collapse
2.0
11.8
151
792
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
11.7
352
2434
N01
ICPC
Headache
2.3
11.6
112
517
L01
ICPC
Neck symptom/complaint
2.0
11.6
161
872
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
11.5
369
2592
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
11.5
252
1593
N06AX11
ATC
mirtazapine; oral
1.6
11.4
372
2624
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
11.4
234
1449
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
11.2
84
339
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
11.0
176
1001
A28
ICPC
Limited function/disability NOS
1.8
10.7
199
1193
G43.9
ICD-10 Finland
Migraine, unspecified
2.9
10.7
63
223
R03AC02
ATC
salbutamol; inhalant
1.5
10.6
583
4625
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
10.5
584
4642
DC1AD
NOMESCO Finland
Temporalbone CT
7.5
10.2
23
31
L28
ICPC
Limited function/disability (L)
1.8
10.2
203
1242
C10AA05
ATC
atorvastatin; oral
1.5
10.2
456
3445
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
10.2
109
528
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.2
10.1
104
496
N02AX02
ATC
tramadol; systemic, rectal
1.5
10.0
485
3730
A02BC01
ATC
omeprazole; systemic
1.6
9.9
337
2388
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
9.8
87
387
M54.5
ICD-10 Finland
Low back pain
1.5
9.8
356
2563
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
9.8
209
1308
A04
ICPC
Weakness/tiredness general
1.8
9.8
163
942
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
9.7
228
1463
N06AX21
ATC
duloxetine; oral
2.0
9.7
127
670
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
9.7
205
1279
H93.1
ICD-10 Finland
Tinnitus
2.4
9.6
81
352
UJF32
NOMESCO Finland
Coloscopy
1.6
9.6
306
2131
A01
ICPC
Pain general/multiple sites
2.2
9.5
100
480
A02BC03
ATC
lansoprazole; oral
1.5
9.5
357
2586
J01AA02
ATC
doxycycline; systemic
1.5
9.4
898
7905
PA7BD
NOMESCO Finland
CT angiography of neck and brain
4.6
9.4
31
68
H80.9
ICD-10 Finland
Otosclerosis, unspecified
100.8
9.4
10
*
3861A
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Other and unspecified peripheral vertigo
+∞
9.4
9
*
D09
ICPC
Nausea
3.0
9.4
54
188
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
9.3
114
585
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
9.3
101
495
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
9.2
517
4075
M54.2
ICD-10 Finland
Cervicalgia
2.3
9.2
86
393
A02BC05
ATC
esomeprazole; systemic
1.5
9.1
461
3558
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.0
9.0
116
608
H91.9
ICD-10 Finland
Hearing loss, unspecified
2.8
8.9
56
205
N06AB10
ATC
escitalopram; oral
1.7
8.8
209
1341
TAB00
NOMESCO Finland
Lumbar puncture
2.8
8.8
55
200
R52.9
ICD-10 Finland
Pain, unspecified
2.1
8.8
106
540
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
8.8
209
1345
J01FA06
ATC
roxithromycin; oral
1.5
8.8
455
3517
R50.9
ICD-10 Finland
Fever, unspecified
1.8
8.8
158
936
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
8.7
551
4433
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
8.7
492
3873
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.2
8.7
92
444
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
2.2
8.7
90
433
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.9
8.6
51
182
N06AB04
ATC
citalopram; systemic
1.6
8.6
242
1626
L17
ICPC
Foot/toe symptom/complaint
1.6
8.6
282
1970
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
8.5
253
1728
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
2.5
8.4
62
252
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
8.3
426
3276
K02.1
ICD-10 Finland
Caries of dentine
1.4
8.3
574
4681
R4110
NOMESCO Finland
Physiotherapy
1.5
8.3
307
2206
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
8.2
282
1990
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.9
8.2
127
712
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
3.1
8.2
43
142
R05
ICD-10 Finland
Cough
1.6
8.2
212
1391
N05CF01
ATC
zopiclone; oral
1.5
8.2
378
2844
DFF15
NOMESCO Finland
Speech audiometry
2.5
8.2
60
243
Z3226
NOMESCO Finland
Physiotherapist
1.6
8.1
217
1442
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
8.1
176
1101
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
8.0
581
4766
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
8.0
105
557
H81
ICD-10 Finland
Disorders of vestibular function
22.2
8.0
11
5
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
7.9
137
802
M25.5
ICD-10 Finland
Pain in joint
1.5
7.8
303
2194
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
7.7
450
3538
A11
ICPC
Chest pain NOS
2.0
7.7
96
496
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
7.7
106
569
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
7.6
409
3163
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.0
7.6
95
493
WX892
NOMESCO Finland
Monitored bed care
2.0
7.6
93
480
N05AH04
ATC
quetiapine; oral
1.7
7.5
166
1042
L29
ICPC
Musculoskeletal sympt/complt other
2.0
7.5
90
461
R01AD09
ATC
mometasone; nasal
1.4
7.4
460
3654
I20.09
ICD-10 Finland
Unstable angina
2.2
7.4
74
352
G04CA02
ATC
tamsulosin; oral
1.6
7.3
223
1527
3860A
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Ménière's disease
+∞
7.3
7
*
N06AX16
ATC
venlafaxine; oral
1.8
7.3
138
828
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.2
526
4296
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.3
7.2
62
272
XF404
NOMESCO Finland
Ambulatory ECG
1.9
7.2
108
602
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
7.2
210
1423
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
7.1
194
1290
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
7.1
88
458
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
7.1
75
366
H29
ICPC
Ear symptom/complaint other
1.8
7.1
116
665
KMAK
NOMESCO Finland
NA
1.4
7.0
520
4252
P03
ICPC
Feeling depressed
2.0
7.0
85
438
J01CA04
ATC
amoxicillin; systemic
1.4
7.0
878
7855
J01DA01
ATC
[U] cefalexin; systemic
1.4
7.0
703
6052
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
7.0
102
562
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.9
436
3458
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
6.9
284
2073
I95.1
ICD-10 Finland
Orthostatic hypotension
2.6
6.9
48
190
WX110
NOMESCO Finland
Local anesthesy
1.4
6.9
725
6285
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
6.9
253
1805
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
4.2
6.8
24
58
R03DC03
ATC
montelukast; oral
1.6
6.8
167
1082
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.8
176
1157
A02BA02
ATC
ranitidine; systemic
1.5
6.8
231
1622
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.8
6.7
41
151
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
6.7
74
366
M54.6
ICD-10 Finland
Pain in thoracic spine
2.1
6.7
74
367
M48.0
ICD-10 Finland
Spinal stenosis
1.7
6.7
146
916
N05BA01
ATC
diazepam; systemic, rectal
1.7
6.7
152
966
Z71.8
ICD-10 Finland
Other specified counselling
1.5
6.7
239
1697
L03
ICPC
Low back symptom/complaint
1.5
6.6
248
1776
R06AE53
ATC
cyclizine, combinations; systemic
5.2
6.6
19
37
G43.8
ICD-10 Finland
Other migraine
5.2
6.6
19
37
K24
ICPC
Fear of heart disease
3.0
6.6
35
118
TDA90
NOMESCO Finland
Removal wax from ear
4.2
6.6
23
55
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.6
383
2988
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.8
6.5
20
42
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.5
419
3328
J01FA10
ATC
azithromycin; systemic
1.4
6.5
591
4978
Z01.2
ICD-10 Finland
Dental examination
1.4
6.5
414
3287
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.4
6.5
52
222
K30
ICD-10 Finland
Functional dyspepsia
1.8
6.5
116
687
R13
ICD-10 Finland
Dysphagia
2.1
6.5
74
372
K07.60
ICD-10 Finland
Snapping jaw
2.5
6.5
49
204
C01DA14
ATC
isosorbide mononitrate; oral
1.5
6.4
198
1358
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.8
6.4
112
657
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
6.4
477
3883
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.0
6.4
80
419
H02
ICPC
Hearing complaint
1.7
6.4
133
823
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
6.3
278
2055
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.8
6.3
37
133
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
6.3
126
774
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.5
6.2
27
79
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
6.2
112
664
G47.3
ICD-10 Finland
Sleep apnoea
1.5
6.2
205
1426
K89
ICPC
Transient cerebral ischaemia
5.1
6.2
18
36
N06AA09
ATC
amitriptyline; systemic
1.7
6.2
120
726
L08
ICPC
Shoulder symptom/complaint
1.5
6.2
191
1310
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.5
6.2
45
185
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
6.2
233
1670
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
6.2
74
380
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.7
6.1
40
153
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
6.1
58
270
D02
ICPC
Abdominal pain epigastric
2.1
6.1
67
330
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
6.1
290
2177
N05BA04
ATC
oxazepam; oral
1.4
6.1
271
2009
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
6.1
258
1893
C09CA03
ATC
valsartan; oral
1.8
6.1
102
591
Z2445
NOMESCO Finland
Psychologist
2.6
6.1
40
155
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
6.1
198
1375
M01AH05
ATC
etoricoxib; oral
1.3
6.0
610
5203
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.4
6.0
49
210
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
6.0
105
614

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
598
3547
2.20
43.55
2.4
2.1
u/l
163.7
244.2
1.31
576
3323
(3018677) aPTT in Platelet poor plasma by Coagulation assay
361
1780
2.39
40.47
2.0
2.0
s
28.6
29.7
3.67
350
1727
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
430
2289
2.27
40.27
4.4
3.9
ng/l
366.4
373.8
0.02
341
1865
(3013826) Glucose [Moles/volume] in Serum or Plasma
940
6784
2.18
39.83
5.1
4.7
mmol/l
6.7
6.8
0.79
899
6342
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
763
5330
1.95
32.31
6.1
5.9
mmol/l
1.2
1.2
0.67
701
4798
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
675
4542
1.94
31.78
5.0
3.7
ng/l
44.7
48.6
0.09
470
3268
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
815
5890
1.92
30.42
7.3
6.7
mmol/l
1.2
1.2
1.84
699
4951
(3013707) Erythrocyte sedimentation rate by Westergren method
1061
8458
2.07
28.87
4.9
4.1
mm/h
12.8
13.2
0.35
990
7755
(3032080) INR in Blood by Coagulation assay
681
4815
1.81
25.50
10.5
9.9
inr
1.3
1.3
0.52
185
1351
(3031040) Bacteria [#/volume] in Urine by Automated count
964
7667
1.83
23.39
6.3
4.8
e6/l
548.9
2620.5
1.35
16
116
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1278
11239
2.65
23.37
20.8
15.0
mg/l
21.1
24.9
4.31
1076
8999
(3037467) Urinalysis macro (dipstick) panel - Urine
986
7922
1.84
22.83
6.0
4.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
531
3654
1.73
20.52
3.4
3.0
ng/l
1349.3
1541.6
0.57
463
3133
(3024561) Albumin [Mass/volume] in Serum or Plasma
690
5140
1.68
19.57
4.3
4.6
g/l
35.6
35.1
1.51
629
4755
(3018418) pH of Serum or Plasma
511
3519
1.71
19.44
4.0
3.9
ph
7.4
7.4
1.10
78
662
(42870588) Differential panel, method unspecified - Blood
544
3818
1.70
19.24
6.6
5.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
664
4916
1.67
19.13
2.3
2.0
pmol/l
95.2
95.0
0.03
325
2478
(3021960) Folate [Moles/volume] in Serum or Plasma
431
2855
1.74
18.73
1.6
1.6
nmol/l
21.8
20.5
0.82
376
2394
(3026008) Bacteria identified in Urine by Culture
542
3856
1.66
17.86
4.0
3.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
778
6064
1.64
17.81
5.5
6.1
umol/l
11.3
11.5
0.19
741
5754
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1052
8891
1.75
17.42
8.1
7.4
u/l
77.8
79.3
0.50
1001
8320
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
878
7086
1.65
17.21
3.4
3.1
u/l
47.6
51.1
0.58
814
6551
(3023103) Potassium [Moles/volume] in Serum or Plasma
1292
11710
2.41
16.97
23.7
17.7
mmol/l
4.0
4.0
1.57
1268
11367
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
510
3618
1.65
16.73
2.8
2.5
u/l
57.0
57.0
0.00
464
3326
(3019550) Sodium [Moles/volume] in Serum or Plasma
1288
11679
2.35
16.54
23.6
17.6
mmol/l
139.5
139.6
0.35
1268
11355
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1027
8683
1.69
16.28
4.7
4.1
pmol/l
14.9
14.9
0.04
948
7826
(3018010) Neutrophils/100 leukocytes in Blood
690
5318
1.59
15.79
7.1
5.7
%
57.8
57.8
0.02
642
4952
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
313
1978
1.75
15.67
2.0
1.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
666
5103
1.58
15.54
7.3
5.8
%
0.6
0.7
0.78
622
4734
(3019069) Monocytes/100 leukocytes in Blood
682
5276
1.57
15.12
7.8
6.1
%
9.0
8.7
1.32
636
4912
(3006504) Eosinophils/100 leukocytes in Blood
679
5256
1.57
14.95
7.2
5.8
%
2.8
2.8
0.02
632
4866
(3002030) Lymphocytes/100 leukocytes in Blood
694
5400
1.57
14.93
7.4
5.9
%
27.0
27.3
0.31
644
5004
(3006315) Basophils [#/volume] in Blood
714
5594
1.57
14.89
6.4
5.6
e9/l
0.0
0.0
0.34
606
4794
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
794
6388
1.56
14.61
3.2
2.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
725
5718
1.56
14.55
6.6
5.6
e9/l
1.9
1.9
0.03
633
4984
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1171
10374
1.81
14.48
5.9
4.9
mu/l
1.9
2.1
0.99
1087
9396
(3001604) Monocytes [#/volume] in Blood
709
5571
1.55
14.41
6.2
5.6
e9/l
0.6
0.6
1.74
600
4765
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
371
2510
1.65
14.24
2.0
1.6
mg/l
1.1
1.2
0.27
284
1938
(3013115) Eosinophils [#/volume] in Blood
731
5797
1.55
14.16
6.7
5.8
e9/l
0.2
0.2
0.01
640
5041
(3003396) Base excess in Arterial blood by calculation
230
1371
1.81
13.91
5.2
7.4
mmol/l
1.0
1.2
0.45
174
1078
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
137
686
2.11
13.83
2.7
2.5
au/ml
22.9
16.3
—
9
33
(3033658) Prothrombin time (PT) actual/Normal
417
2927
1.61
13.71
3.9
3.8
%
88.5
89.1
0.18
407
2854
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
228
1376
1.79
13.19
5.2
7.4
kpa
5.0
5.1
1.54
222
1315
(3027801) Oxygen [Partial pressure] in Arterial blood
228
1376
1.79
13.19
5.2
7.4
kpa
12.2
12.0
0.14
223
1317
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
66
245
2.78
12.93
1.3
1.4
e6/l
89.8
15.3
0.60
50
193
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
66
245
2.78
12.93
1.3
1.5
e6/l
3213.1
1066.6
0.32
50
203
(3013650) Neutrophils [#/volume] in Blood by Automated count
801
6563
1.52
12.76
9.3
8.8
e9/l
4.3
4.1
1.11
686
5719
(3016502) Oxygen saturation in Arterial blood
204
1209
1.81
12.50
5.6
7.9
%
95.5
95.4
0.07
199
1169
(3023368) Bacteria identified in Blood by Culture
455
3319
1.55
12.43
4.2
4.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
544
4133
1.52
12.28
4.4
3.7
e6/l
197.5
123.9
0.34
374
2958
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
612
4789
1.50
11.86
2.6
2.2
nmol/l
78.8
78.7
0.05
545
4251
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1161
10415
1.69
11.79
6.7
6.0
mmol/mol
40.5
40.2
0.47
1079
9562
(3048689) Calprotectin [Mass/mass] in Stool
207
1255
1.76
11.71
2.3
2.1
ug/g
137.0
124.4
0.19
161
975
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
281
1853
1.65
11.65
3.6
2.9
e6/l
1.8
2.6
1.70
147
1017
(3044290) Cell count panel - Cerebral spinal fluid
57
207
2.83
11.65
1.2
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
476
3546
1.52
11.64
3.8
3.3
e6/l
37.1
82.4
1.37
348
2761
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
484
3622
1.52
11.57
3.2
3.1
u/l
31.2
33.9
0.76
453
3435
(3001122) Ferritin [Mass/volume] in Serum or Plasma
612
4819
1.48
11.34
3.1
2.7
ug/l
113.1
128.3
1.34
563
4391
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
337
2340
1.58
11.26
1.3
1.2
u/ml
1.1
1.6
0.53
68
601
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
295
1991
1.61
11.09
3.3
2.8
e6/l
1.1
1.2
0.19
160
1150
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
222
1397
1.70
10.96
1.9
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
221
1398
1.69
10.69
1.9
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
281
1890
1.61
10.68
1.4
1.2
iu/ml
25.2
33.6
0.65
79
598
(40761511) CBC panel - Blood by Automated count
1261
11663
1.85
10.40
19.3
14.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
177
1070
1.75
10.06
2.3
2.2
u/l
30.4
37.4
1.43
156
908
(36304419) Bacteria [Presence] in Urine
424
3164
1.49
9.97
3.6
3.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
686
5614
1.44
9.92
4.8
3.9
estimate
0.0
0.0
0.00
103
1038
(3037522) Nuclear Ab [Titer] in Serum
219
1408
1.66
9.92
1.4
1.3
titre
634.3
521.2
0.26
42
313
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
205
1299
1.68
9.81
3.5
3.9
u/l
239.9
254.7
0.78
188
1224
(3015377) Calcium [Moles/volume] in Serum or Plasma
531
4154
1.45
9.75
2.8
3.4
mmol/l
2.4
2.4
0.59
440
3595
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1279
11925
1.88
9.66
12.6
10.5
u/l
24.7
25.3
0.67
1241
11467
(3021601) Nitrite [Presence] in Urine by Test strip
685
5637
1.42
9.43
6.6
5.4
estimate
0.0
0.0
0.50
105
1047
(3030467) Casts [#/volume] in Urine by Automated count
432
3274
1.46
9.27
3.7
3.1
e6/l
0.4
0.5
0.15
315
2510
(3009261) Glucose [Presence] in Urine by Test strip
689
5697
1.41
9.12
4.9
4.0
estimate
0.0
0.0
0.50
102
1017
(3007164) IgA [Mass/volume] in Serum or Plasma
291
2047
1.53
8.95
1.4
1.4
g/l
2.3
2.4
0.56
150
1210
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
403
3041
1.46
8.75
2.5
2.2
mg/l
2.7
3.1
4.23
354
2564
(3009542) Hematocrit [Volume Fraction] of Blood
1112
10087
1.51
8.47
22.1
16.3
%
39.2
39.2
0.06
758
6901
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
170
1068
1.67
8.37
3.1
3.0
ng/l
217.9
234.1
0.10
159
977
(36660697) Celiac disease serology panel - Serum
138
820
1.76
8.31
1.2
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
273
1924
1.52
8.27
2.7
3.1
mmol/l
0.8
0.8
0.85
255
1794
(3019309) Folate [Moles/volume] in Red Blood Cells
323
2370
1.47
8.01
1.8
1.8
nmol/l
1067.9
1205.7
1.97
247
1750
(3044889) 12 lead EKG panel
919
8079
1.40
8.01
4.6
4.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
14
7.91
7.99
1.0
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
232
1590
1.55
7.97
33.6
26.5
inr
1.4
1.4
0.05
30
193
(3019060) Gas panel - Arterial blood
135
808
1.74
7.93
3.3
5.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
652
5423
1.38
7.92
4.1
4.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1309
12402
1.91
7.83
30.0
22.1
e9/l
247.4
250.1
0.83
1287
12069
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
126
743
1.76
7.79
1.8
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
142
867
1.71
7.77
1.8
1.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
1309
12406
1.90
7.77
29.9
22.0
fl
91.1
91.3
1.05
1295
12198
(3035941) MCH [Entitic mass]
1309
12407
1.90
7.75
29.9
22.0
pg
30.3
30.3
0.19
1295
12197
(3026361) Erythrocytes [#/volume] in Blood
1309
12408
1.90
7.73
30.0
22.1
e12/l
4.4
4.4
0.24
1283
12030
(3010813) Leukocytes [#/volume] in Blood
1309
12409
1.90
7.71
30.1
22.1
e9/l
7.0
6.8
1.75
1282
12033
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
257
1813
1.51
7.71
1.4
1.2
u/ml
25.8
13.1
0.29
86
665
(3000963) Hemoglobin [Mass/volume] in Blood
1309
12411
1.90
7.68
30.1
22.2
g/l
133.6
133.6
0.02
1295
12201
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
196
1304
1.59
7.65
2.1
2.5
umol/l
9.2
8.6
0.09
173
1128
(3008152) Bicarbonate [Moles/volume] in Arterial blood
128
763
1.75
7.63
4.8
7.3
mmol/l
24.4
24.5
0.14
123
713
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
109
621
1.82
7.57
7.0
10.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1185
10965
1.54
7.51
5.3
4.7
mmol/l
6.0
6.0
0.42
1095
9877
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
75
378
2.04
7.49
1.7
2.3
g/l
37.5
37.5
0.00
64
327
(3027945) Reticulocytes/100 erythrocytes in Blood
203
1369
1.57
7.47
2.3
2.4
%
2.0
1.8
0.97
184
1198
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
442
1.96
7.44
1.9
2.5
g/l
9.8
10.4
0.65
70
378
(3011985) Renin [Units/volume] in Plasma
37
137
2.75
7.38
1.4
1.4
mu/l
50.5
42.8
0.12
32
124
(3002385) Erythrocyte distribution width [Ratio]
1026
9247
1.41
7.35
24.4
18.3
%
13.7
13.8
0.34
1012
9026
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
72
360
2.05
7.35
1.7
2.3
g/l
0.1
0.0
0.49
67
329
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
444
1.95
7.34
1.8
2.5
g/l
3.1
3.2
0.07
66
351
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
473
1.92
7.33
1.9
2.4
g/l
3.7
3.7
0.25
65
345
(3003458) Phosphate [Moles/volume] in Serum or Plasma
226
1568
1.53
7.31
5.4
5.3
mmol/l
1.0
1.0
0.19
204
1435
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
474
1.91
7.28
1.9
2.4
g/l
7.5
7.5
0.06
66
360
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
474
1.91
7.28
1.9
2.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
334
2517
1.43
7.09
5.3
4.3
kg/l
1.0
1.0
0.60
53
374
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1146
10566
1.48
7.04
18.4
14.0
ml/min/173m2
78.4
77.9
0.35
948
8727
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
23
66
3.53
7.00
1.0
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
556
4573
1.36
6.97
2.1
2.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
225
1576
1.51
6.94
2.4
2.5
%
23.0
22.5
0.17
188
1341
(3004789) Transferrin [Mass/volume] in Serum or Plasma
238
1689
1.49
6.89
2.4
2.4
g/l
2.3
2.3
0.14
224
1557
(3023520) Reticulocytes [#/volume] in Blood
158
1024
1.61
6.87
2.4
2.5
e9/l
76.0
70.6
0.78
127
775
(3022948) Iron [Moles/volume] in Serum or Plasma
254
1828
1.48
6.86
2.5
2.4
umol/l
13.3
12.7
0.52
238
1678
(3036481) Cortisol [Moles/volume] in Serum or Plasma
161
1049
1.60
6.85
1.8
2.0
nmol/l
363.8
379.4
0.48
148
954
(3003327) Ova and parasites identified in Stool by Light microscopy
65
322
2.07
6.82
1.6
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
341
2597
1.41
6.79
1.8
1.7
pmol/l
36268042.0
16358015.4
0.32
284
2103
(3023410) Appearance of Cerebral spinal fluid
30
104
2.93
6.76
1.2
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
29
99
2.97
6.72
1.0
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
349
2676
1.41
6.67
4.5
3.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
29
100
2.94
6.60
1.1
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
77
412
1.92
6.52
1.9
2.5
g/l
0.4
1.3
1.76
68
361
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
67
342
2.01
6.50
1.7
2.4
g/l
0.0
0.0
0.00
62
312
(3000850) Epithelial cells [#/volume] in Urine
329
2510
1.41
6.45
2.6
2.6
e6/l
5.9
6.2
0.17
283
2210
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
28
96
2.96
6.45
1.1
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
152
994
1.59
6.37
1.9
2.9
g/l
65.8
66.5
0.73
128
902
(4027681)
20
56
3.61
6.32
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
313
2375
1.41
6.32
3.0
2.8
mosm/kgh2o
550.3
542.9
0.23
260
2028
(3003338) MCHC [Mass/volume]
1022
9290
1.38
6.31
26.9
19.7
g/l
332.0
331.6
0.61
1016
9204
(3014111) Lactate [Moles/volume] in Serum or Plasma
157
1038
1.58
6.28
6.0
6.7
mmol/l
1.2
1.4
2.41
149
995
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
146
949
1.60
6.27
3.7
3.6
ng/l
91.2
90.4
0.03
128
815
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
40
170
2.39
6.09
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
105
2.80
6.07
1.3
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
44
3.90
5.99
1.1
2.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
81
457
1.82
5.85
1.7
1.9
u/l
39.0
39.1
0.01
72
401
(3000991) Gas panel - Venous blood
145
960
1.57
5.77
6.9
8.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
364
2871
1.36
5.75
6.8
6.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
128
825
1.61
5.70
1.8
2.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
111
691
1.66
5.68
4.1
3.7
mmol/l
1.6
1.9
0.40
88
518
(3022145) Colonoscopy Study observation
177
1230
1.50
5.64
1.3
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
32
128
2.54
5.56
1.3
1.4
pmol/l
300.4
291.9
0.06
27
98
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
66
355
1.90
5.54
1.5
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
114
720
1.64
5.52
1.7
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
221
1613
1.44
5.49
1.5
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
373
2972
1.35
5.49
2.5
2.6
umol/l
5949.0
6923.5
0.14
309
2547
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1136
10582
1.40
5.47
4.3
4.0
mmol/l
1.3
1.3
1.59
1043
9549
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
105
652
1.66
5.43
2.5
2.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
125
811
1.59
5.42
2.2
2.9
g/l
10.3
10.7
0.54
114
741
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
28
107
2.65
5.33
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
10
19
5.29
5.04
1.1
1.1
—
—
—
0
0
(3013512) EKG study
419
3433
1.32
5.02
5.2
4.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1195
11269
1.42
5.01
5.7
5.0
mmol/l
2.6
2.7
1.94
1106
10254
(3009343) pH of Capillary blood
112
722
1.60
5.01
4.1
3.7
ph
7.4
7.4
0.07
11
92
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
113
732
1.59
4.95
4.1
3.7
kpa
5.3
5.2
0.55
103
677
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
87
531
1.68
4.83
1.6
1.9
g/l
1.6
1.5
0.53
73
463
(3014007) Fractional oxyhemoglobin in Arterial blood
112
730
1.58
4.79
7.3
8.9
%
93.8
93.8
0.01
112
725
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
11
24
4.61
4.78
1.5
1.1
ug/l
0.4
0.4
—
5
13
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1164
10952
1.38
4.73
4.9
4.4
mmol/l
1.4
1.5
5.09
1074
9951
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1171
11047
1.38
4.52
5.0
4.5
mmol/l
4.6
4.6
1.79
1090
10109
(4010399)
119
798
1.54
4.50
1.4
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
297
2349
1.34
4.50
2.8
3.0
mmol/l
2.5
2.5
0.21
249
2053
(3013139) Helicobacter pylori Ag [Presence] in Stool
108
713
1.56
4.39
1.3
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
29
125
2.35
4.36
1.2
1.2
nmol/l
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
156
1114
1.45
4.35
3.8
3.5
mmol/l
2.3
2.0
0.48
132
901
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
42
211
2.02
4.35
1.3
1.2
u/ml
41.3
33.9
—
5
16
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
347
2825
1.30
4.26
2.4
2.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
211
1599
1.38
4.20
1.3
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
18
62
2.93
4.18
1.1
1.0
u/l
1.1
1.1
—
7
33
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
26
109
2.41
4.16
1.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
440
3703
1.28
4.16
2.5
2.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
92
594
1.59
4.12
1.4
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
30
135
2.25
4.10
1.3
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
18
63
2.88
4.07
1.2
1.1
iu/ml
9.8
10.9
—
6
16
(3007853) Bacteria identified in Skin by Aerobe culture
181
1348
1.39
4.00
1.9
1.7
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
20
75
2.69
4.00
1.3
1.4
—
335.6
—
0
9
(3009508) Creatinine [Moles/volume] in Urine
425
3576
1.27
3.99
3.0
3.1
mmol/l
7.2
7.2
0.12
342
2982
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
99
656
1.55
3.98
3.2
3.3
pmol/l
4.3
4.5
1.44
85
573
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
57
328
1.77
3.95
1.5
1.5
g/l
1.2
1.2
0.00
51
306
(3039162) Centromere protein B Ab [Units/volume] in Serum
29
133
2.21
3.81
1.2
1.2
—
62.8
—
0
6
(3011288) Drugs identified in Urine by Screen method
34
167
2.06
3.77
1.4
2.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
46
252
1.85
3.75
1.5
2.1
g/l
135.0
127.7
1.17
34
185
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
44
240
1.86
3.64
2.8
1.9
u/l
5287.6
3815.2
0.16
13
99
(3026389) Candida sp identified in Specimen by Organism specific culture
30
143
2.12
3.60
1.6
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
84
550
1.56
3.58
2.9
3.9
mmol/l
24.7
24.2
0.70
78
494
(3051593) INR in Capillary blood by Coagulation assay
16
57
2.83
3.53
13.0
11.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
32
158
2.05
3.52
1.1
1.8
g/l
0.6
0.9
0.99
22
122
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
174
1318
1.37
3.48
1.5
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
50
289
1.76
3.45
2.5
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
499
4340
1.23
3.40
5.5
4.2
—
—
—
0
0
(3036489) Thrombin time
65
406
1.63
3.38
2.1
1.8
s
20.5
21.5
1.32
57
364
(3022313) Gas panel - Capillary blood
80
526
1.55
3.36
4.7
3.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
373
3148
1.25
3.33
4.9
5.0
ug/l
2.7
3.0
0.18
338
2806
(3021589) Normoblasts [#/volume] in Blood
567
5014
1.22
3.26
10.4
9.5
e9/l
0.0
0.0
0.51
447
4082
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
257
1.78
3.24
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
257
1.78
3.24
1.3
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
145
1079
1.38
3.24
2.6
2.4
ug/l
6.4
7.2
0.14
118
945
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
19
4.76
3.24
1.2
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
258
1.77
3.21
1.3
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
59
365
1.64
3.20
2.6
3.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
29
144
2.04
3.17
1.3
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
61
382
1.62
3.16
1.3
1.2
u/ml
0.3
1.1
—
8
29
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
354
2988
1.25
3.14
1.7
1.6
mmol/l
1.3
1.4
0.07
307
2501
(3045414) Leukocytes [Presence] in Urine
79
527
1.53
3.13
2.1
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
35
187
1.89
3.12
1.1
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
15
56
2.70
3.06
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
53
323
1.67
3.06
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
150
1134
1.36
3.05
1.7
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
44
255
1.75
3.04
1.4
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
106
758
1.43
2.99
3.5
2.9
e9/l
3.9
4.2
0.42
78
581
(4094501)
50
302
1.68
2.99
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
41
234
1.77
2.99
1.7
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
44
257
1.74
2.96
1.4
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
31
162
1.93
2.96
1.8
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
112
811
1.41
2.95
3.7
3.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
354
3007
1.24
2.95
4.7
3.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
251
1.74
2.91
1.6
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
75
505
1.51
2.87
1.1
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
46
276
1.69
2.83
1.4
1.2
u/ml
3.4
12.8
—
5
47
(3023323) Follitropin [Units/volume] in Serum or Plasma
59
378
1.59
2.82
1.4
1.3
iu/l
32.0
30.7
0.11
54
324
(4062490)
22
103
2.15
2.81
1.1
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
417
3621
1.22
2.79
3.8
3.9
mg/mmol
10.0
9.2
0.10
241
2242
(3000764) Benzodiazepines [Presence] in Urine
43
255
1.71
2.77
1.4
1.6
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
6
8.36
2.75
1.4
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
47
287
1.66
2.72
1.2
1.2
—
13.0
—
0
5
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
66
2.44
2.71
1.8
2.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
50
311
1.63
2.70
2.4
2.1
%
177.8
192.2
0.57
45
297
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
301
2535
1.24
2.70
4.1
4.3
%
21.8
21.4
0.20
134
1253
(3017143) Hepatitis C virus Ab [Presence] in Serum
139
1060
1.35
2.69
1.6
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
95
680
1.43
2.69
1.3
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
54
343
1.60
2.68
1.3
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
73
497
1.49
2.67
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
27
140
1.95
2.66
1.6
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
179
1419
1.30
2.65
4.8
4.5
%
32.0
32.7
0.28
120
932
(3016879) Cocaine [Presence] in Urine
40
237
1.71
2.60
1.4
1.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
15
4.68
2.60
1.7
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
42
253
1.68
2.57
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
142
1.92
2.56
1.8
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20
94
2.14
2.55
1.0
1.3
—
—
—
0
0
(3019225) pH of Specimen
150
1167
1.32
2.55
5.2
4.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
53
340
1.58
2.54
1.3
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
53
340
1.58
2.54
1.6
1.4
ug/g
262.7
283.9
0.28
30
194
(3028192) IgG subclass 2 [Mass/volume] in Serum
21
101
2.10
2.53
1.1
1.5
g/l
2.9
2.8
0.07
14
74
(3027135) IgG subclass 1 [Mass/volume] in Serum
21
101
2.10
2.53
1.1
1.5
g/l
5.6
7.2
1.51
14
76
(3024139) IgG subclass 3 [Mass/volume] in Serum
21
101
2.10
2.53
1.1
1.5
g/l
0.3
0.4
1.49
14
74
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
33
187
1.78
2.50
6.0
5.4
iu/ml
390.1
311.9
—
7
19
(4306422)
28
151
1.87
2.48
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
142
1105
1.32
2.42
2.0
2.1
g/l
0.2
0.2
1.00
134
1022
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
50
321
1.58
2.41
2.1
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
207
1693
1.26
2.40
2.0
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
69
476
1.47
2.39
2.1
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
102
756
1.38
2.39
1.8
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
90
653
1.40
2.39
2.3
2.2
nmol/l
11.6
13.1
0.76
78
569
(3000034) Microalbumin [Mass/volume] in Urine
20
97
2.08
2.37
2.1
3.2
mg/l
18.3
17.5
0.03
13
67
(3020779) Urea [Moles/volume] in Serum or Plasma
134
1037
1.32
2.37
7.0
7.1
mmol/l
10.3
10.3
0.02
121
986
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
8
6.27
2.37
1.4
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
58
2.43
2.37
1.5
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
53
347
1.55
2.35
1.3
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
19
91
2.10
2.33
2.7
1.9
e9/l
1.4
1.0
1.39
13
57
(1001926) Buprenorphine [Presence] in Urine by Screen method
34
199
1.73
2.33
1.5
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
390
3417
1.20
2.32
3.2
3.2
mg/l
620.6
361.6
0.35
240
2133
(3000494) Fungus identified in Specimen by Culture
168
1347
1.28
2.30
1.5
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
18
85
2.13
2.29
1.9
1.4
u/ml
27.5
19.2
—
6
14
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
13
53
2.47
2.28
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
74
524
1.44
2.26
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
45
287
1.59
2.24
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
43
273
1.59
2.19
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
48
313
1.55
2.19
1.5
1.6
iu/ml
35.2
19.1
—
10
63
(3000492) Spirometry study
131
1025
1.31
2.16
1.6
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
14
4.30
2.15
1.5
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
9
30
3.01
2.15
1.6
2.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
60
413
1.47
2.13
3.1
3.0
g/l
0.4
0.3
0.36
20
159
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
29
167
1.75
2.12
1.2
1.2
u/ml
1.3
2.2
—
10
50
(3028026) IgM [Mass/volume] in Serum or Plasma
88
651
1.38
2.11
1.6
1.8
g/l
1.0
1.5
2.72
80
600
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
116
1.91
2.11
1.6
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
153
1.78
2.09
1.1
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
20
3.51
2.05
1.0
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
15
4.01
2.04
1.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
64
451
1.44
2.03
2.2
2.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
30
177
1.71
2.03
1.1
1.2
u/ml
230.6
272.1
0.44
14
101
(3000330) Specific gravity of Urine by Test strip
88
657
1.36
2.01
4.3
3.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
63
2.23
2.01
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
93
702
1.35
1.98
1.2
1.2
iu/ml
67.9
140.1
2.43
30
271
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
57
2.29
1.98
1.1
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
141
1.79
1.97
1.8
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
67
480
1.42
1.96
1.7
1.9
ug/l
0.6
1.9
1.35
58
420
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
143
1149
1.27
1.95
1.7
1.8
%
1.5
1.5
0.14
118
990
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
142
1.77
1.93
1.8
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
120
1.85
1.93
1.5
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
46
307
1.52
1.92
1.4
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
37
235
1.59
1.91
2.3
2.3
%
17.0
15.9
0.53
15
121
(3016650) Hepatitis A virus Ab [Presence] in Serum
29
173
1.69
1.90
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
128
1.81
1.90
5.6
4.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
107
832
1.31
1.88
2.0
2.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
24
136
1.78
1.88
12.5
7.9
mmol/l
8.1
7.5
0.35
19
113
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
151
1.74
1.87
1.2
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
42
278
1.53
1.83
1.1
1.1
titre
126.7
78.8
—
6
26
(46235355) HIV 1 and 2 tests - Meaningful Use set
185
1543
1.23
1.83
1.7
1.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
76
564
1.37
1.82
5.9
3.7
%
50.8
48.6
0.35
76
557
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
12
4.18
1.82
1.0
2.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
12
4.18
1.82
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
29
2.77
1.79
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
109
1.85
1.77
1.5
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
22
124
1.79
1.76
1.6
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
40
265
1.52
1.75
1.5
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
18
3.34
1.74
1.0
1.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
24
140
1.73
1.72
1.9
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
38
250
1.53
1.72
2.3
3.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
13
3.86
1.71
1.4
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
68
2.07
1.70
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
68
2.07
1.70
1.1
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
172
1.64
1.68
1.2
1.4
u/ml
108.2
139.7
—
5
30
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
31
196
1.59
1.66
1.3
1.4
—
—
—
0
0
(4198724)
7
25
2.81
1.65
1.6
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
69
2.04
1.65
1.1
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
69
2.04
1.65
2.4
1.9
%
11.0
12.8
—
8
32
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
98
1.85
1.62
1.1
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
134
0.37
1.61
1.4
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
77
1.96
1.59
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
70
2.01
1.59
2.0
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
70
2.01
1.59
2.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
22
129
1.72
1.57
2.0
3.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
281
1.47
1.56
1.2
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
115
928
1.26
1.55
5.8
3.9
%
1.0
0.9
0.23
37
265
(4268621)
19
107
1.79
1.55
2.2
2.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
44
2.28
1.53
1.9
2.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
19
108
1.77
1.51
1.3
1.3
—
25.4
—
0
7
(3052592) Norovirus Ag [Presence] in Stool
6
21
2.86
1.50
1.0
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
45
0.00
1.50
0.0
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
18
101
1.79
1.49
1.1
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
18
101
1.79
1.49
6.1
3.4
%
61.8
53.9
0.61
13
73
(3029937) Albumin [Presence] in Urine by Test strip
340
3048
1.15
1.48
5.8
4.2
estimate
0.0
0.0
1.08
105
1007
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
23
140
1.65
1.45
1.9
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
109
882
1.26
1.45
5.5
4.0
%
0.2
0.1
0.23
37
241
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
28
2.51
1.45
1.3
1.2
—
—
—
0
0
(4024509)
18
102
1.77
1.45
1.6
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
73
1.93
1.44
1.2
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
314
0.60
1.42
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
23
141
1.64
1.42
1.9
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
16
88
1.83
1.41
2.3
2.9
%
13.2
10.7
1.26
16
88
(3019832) Treponema pallidum Ab [Presence] in Serum
89
705
1.28
1.41
1.5
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
26
165
1.59
1.41
1.3
1.2
u/ml
6.6
5.8
0.07
11
72
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
46
2.18
1.40
1.9
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
46
2.18
1.40
1.9
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
46
2.18
1.40
1.9
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
58
433
1.35
1.40
2.0
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
60
2.01
1.38
1.7
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
60
2.01
1.38
1.8
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
60
2.01
1.38
1.8
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
60
2.01
1.38
1.8
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
23
2.62
1.37
1.2
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
36
248
1.46
1.36
3.4
4.4
mmol/l
2.1
2.7
0.54
26
168
(3027273) Bicarbonate [Moles/volume] in Venous blood
77
603
1.29
1.35
4.7
3.1
mmol/l
25.8
25.3
0.66
77
585
(3014271) Vancomycin [Susceptibility]
13
68
1.92
1.33
3.2
3.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
16
90
1.79
1.33
1.2
1.1
u/ml
0.1
1.2
0.62
11
47
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
54
2.05
1.33
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
152
1289
1.20
1.31
2.7
4.0
ug/l
70.0
21.1
0.38
114
1067
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
20
121
1.66
1.31
1.4
1.3
mmol/l
7.3
7.6
0.09
11
85
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
39
542
0.71
1.30
1.6
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
36
2.23
1.24
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
171
1.53
1.23
1.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
155
1.56
1.23
1.3
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
10
49
2.05
1.22
1.6
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
49
2.05
1.22
1.2
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
37
2.17
1.21
1.0
2.1
—
74092.3
—
0
6
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
26
2.31
1.18
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
26
2.31
1.18
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
26
2.31
1.18
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
26
2.31
1.18
1.3
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
26
2.31
1.18
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
22
141
1.57
1.17
1.2
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
57
1.94
1.17
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
57
1.94
1.17
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
57
1.94
1.17
1.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
20
2.51
1.15
1.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
64
809
0.78
1.15
1.8
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
22
142
1.56
1.14
1.2
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
388
1.33
1.13
2.3
3.5
mg/l
68.0
46.1
0.26
44
317
(44806420)
8
40
2.01
1.12
2.3
2.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
51
1.97
1.11
2.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
51
1.97
1.11
2.3
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
101
839
1.22
1.11
4.8
3.8
%
0.5
0.5
0.24
26
192
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
17
267
0.63
1.08
1.2
1.5
pmol/l
196.2
269.2
0.30
17
261
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
32
2.19
1.08
1.6
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
59
1.87
1.07
1.0
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
59
1.87
1.07
1.0
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
44
332
1.34
1.04
1.7
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
27
187
1.45
1.04
1.3
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
51
394
1.31
1.03
1.7
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
20
130
1.55
1.03
2.0
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
65
806
0.80
1.01
1.5
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
53
1.89
1.01
2.5
2.8
u/ml
448.5
1051.8
—
10
53
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
336
1.32
0.98
2.2
1.8
—
—
—
0
0
(3010421) pH of Blood
41
310
1.33
0.97
3.5
4.0
ph
7.4
7.4
1.12
34
244
(3023430) Cat dander IgE Ab [Units/volume] in Serum
15
92
1.64
0.97
1.1
1.0
u/ml
0.8
4.3
—
5
40
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
28
199
1.42
0.96
1.2
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
35
259
1.36
0.95
4.1
3.9
mg/l
19.4
25.0
0.55
24
163
(3042111) Morphology [Interpretation] in Bone marrow Narrative
27
191
1.42
0.95
1.3
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
98
827
1.20
0.94
5.6
4.1
%
3.1
0.5
0.41
30
204
(3020891) Body temperature
59
472
1.26
0.94
4.6
4.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
27
2.23
0.93
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
27
2.23
0.93
1.3
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
27
2.23
0.93
4.3
1.9
—
—
—
0
0
(3000012) Reticulocyte production index
12
70
1.72
0.92
1.4
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
52
1.74
0.92
3.8
4.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
28
2.15
0.91
1.3
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
6
28
2.15
0.91
1.0
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
102
1.58
0.90
1.1
1.0
u/ml
1.1
4.6
—
6
40
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
54
430
1.27
0.90
2.2
1.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
29
2.07
0.89
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
29
2.07
0.89
1.3
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
49
386
1.28
0.89
2.4
3.5
mg/l
35.8
66.3
1.12
43
314
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
105
0.47
0.88
1.2
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
79
1.65
0.88
1.2
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
165
1463
1.14
0.88
1.5
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
103
1.56
0.87
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
103
1.56
0.87
1.6
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
103
1.56
0.87
1.6
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
43
1.87
0.87
1.1
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
43
1.87
0.87
1.1
1.1
iu/ml
196.0
203.9
—
8
43
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
170
1.42
0.85
1.0
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
18
120
1.51
0.85
1.2
1.0
u/ml
1.1
4.0
—
5
34
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
34
256
1.34
0.85
1.2
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
348
3739
0.91
0.84
3.1
2.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
80
1.63
0.84
1.0
1.1
titre
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
80
1.63
0.84
2.7
2.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
37
477
0.77
0.82
1.8
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
113
1.51
0.82
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
400
1.26
0.82
3.9
2.7
u/ml
0.3
0.4
0.26
33
227
(3024263) Appearance of Synovial fluid
10
58
1.73
0.79
2.9
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
32
242
1.33
0.79
1.4
1.3
miu/ml
191.2
254.4
0.50
16
108
(40768446) Kidney Pathology biopsy report
6
33
1.82
0.79
1.8
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
48
1.67
0.78
1.1
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
124
0.56
0.78
1.6
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
14
91
1.54
0.75
1.6
1.3
%
27.5
28.3
—
8
56
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
91
1.54
0.75
1.1
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
24
2.09
0.74
1.0
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
133
1.43
0.73
1.2
1.0
u/ml
0.8
1.7
—
6
58
(3021901) Oxygen saturation in Capillary blood
29
219
1.33
0.73
1.6
2.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
125
1.45
0.72
3.2
2.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
142
1266
1.14
0.72
3.7
3.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
39
1.80
0.72
1.3
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
39
1.80
0.72
1.4
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
56
1.61
0.72
1.1
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
76
1.58
0.71
1.7
3.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
151
1.40
0.71
1.2
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
26
1.93
0.70
1.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
26
1.93
0.70
1.6
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
49
400
1.23
0.70
2.3
2.9
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
36
283
1.28
0.70
2.1
1.7
e6/l
12113.2
15499.3
0.26
25
199
(3006653) Thiamine [Moles/volume] in Blood
9
58
1.56
0.70
1.0
1.2
nmol/l
125.9
145.3
—
9
58
(40761535) Cells panel - Urine sediment
112
986
1.15
0.69
4.4
3.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
61
1.64
0.68
1.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
23
171
1.35
0.65
2.4
2.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
62
1.62
0.65
1.4
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
225
1.30
0.63
1.3
1.3
u/l
16.4
10.6
0.94
23
173
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
138
1.38
0.62
1.2
1.0
u/ml
5.5
4.8
—
8
65
(3006270) Folate [Moles/volume] in Blood
15
104
1.45
0.62
1.4
1.1
nmol/l
382.9
367.1
—
10
89
(1617658) Protocol used for examination of sentinel lymph nodes
6
101
0.59
0.62
1.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
30
1.67
0.61
1.2
1.0
miu/ml
1116.2
1643.4
—
5
30
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
30
1.67
0.61
1.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
51
1.57
0.60
1.1
1.3
—
—
—
0
0
(4146454)
17
122
1.40
0.60
3.1
2.7
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
30
236
1.28
0.60
1.4
1.3
mmol/l
62.8
61.2
0.08
24
188
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
183
1.32
0.59
1.8
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
18
131
1.38
0.59
1.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
55
465
1.19
0.58
1.8
3.2
u/ml
22.5
3155.4
0.84
41
400
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
175
1.32
0.58
3.8
2.5
—
—
—
0
0
(1002224) Polysomnography panel
46
383
1.21
0.57
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
18
132
1.37
0.57
1.1
1.4
mosm/kgh2o
275.7
277.5
—
7
96
(21494814) CD8 cells/100 lymphocytes in Specimen
6
36
1.67
0.56
3.5
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
36
1.67
0.56
1.0
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
8
55
1.46
0.56
1.3
2.7
ml
1953.8
1886.4
—
8
49
(3008037) Lactate [Moles/volume] in Venous blood
36
293
1.23
0.56
5.2
3.1
mmol/l
1.5
1.6
0.21
36
287
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
65
1.54
0.55
2.2
2.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
123
0.65
0.54
1.5
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
60
1.50
0.54
1.0
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
11
74
1.49
0.53
1.8
1.4
promille
1.2
1.1
0.09
11
60
(3010838) Calcium [Moles/time] in 24 hour Urine
9
62
1.45
0.53
1.4
1.6
—
11.1
—
0
6
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
39
1.54
0.53
1.8
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
91
1.43
0.53
1.1
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
34
278
1.23
0.51
5.4
3.2
mmol/l
7.3
7.7
0.50
34
273
(40760892) CBC W Ordered Manual Differential panel - Blood
256
2403
1.08
0.51
4.7
4.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
136
1.33
0.49
3.4
3.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
18
136
1.33
0.49
1.6
2.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
45
1.56
0.49
3.1
3.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
46
1.52
0.48
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
21
267
0.78
0.48
1.3
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
199
1.26
0.48
1.4
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
317
3009
1.07
0.47
1.3
1.4
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
7
47
1.49
0.47
1.1
1.2
—
2.3
—
0
8
(44813793)
10
68
1.47
0.47
1.0
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
12
85
1.42
0.47
1.6
1.2
—
70.4
—
0
7
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
48
1.46
0.46
1.0
1.1
—
16.3
—
0
8
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
94
1.39
0.46
2.2
1.5
—
—
—
0
0
(4211845)
7
49
1.43
0.46
3.1
3.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
33
274
1.21
0.45
1.5
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
23
183
1.26
0.45
1.3
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
95
1.37
0.43
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
157
1.28
0.43
1.2
1.1
u/ml
0.1
2.0
—
5
65
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
32
1.56
0.42
2.6
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
32
1.56
0.42
1.2
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
195
1830
1.08
0.41
3.0
3.1
ug/l
0.7
0.8
0.26
125
1232
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
33
1.52
0.41
1.2
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
16
0.00
0.41
0.0
5.3
—
—
—
0
0
(4015189)
5
34
1.47
0.40
1.6
2.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
32
378
0.84
0.39
1.9
1.7
mg/l
5.2
2.7
1.07
25
273
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
35
1.43
0.39
1.2
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
35
1.43
0.39
1.2
2.9
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
5
35
1.43
0.39
1.0
1.2
g/l
33.9
37.8
—
5
20
(3048879) Bone marrow aspiration report
5
37
1.35
0.37
5.0
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.36
1.3
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
42
1.43
0.35
1.2
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
42
1.43
0.35
1.0
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
103
949
1.09
0.35
2.9
2.6
ml/min/173m2
58.5
64.3
0.90
46
402
(3045142) Bone marrow Pathology biopsy report
16
126
1.27
0.35
1.3
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
25
298
0.84
0.35
1.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
167
0.78
0.34
1.5
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
181
1710
1.07
0.33
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
23
191
1.21
0.33
1.6
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
87
0.69
0.33
1.2
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
90
0.67
0.32
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
20
164
1.22
0.32
3.3
2.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
266
1.17
0.32
1.5
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
26
221
1.18
0.30
1.6
1.7
nmol/l
0.8
0.9
0.10
20
182
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
93
1.29
0.30
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
194
1.19
0.29
1.3
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
17
205
0.83
0.28
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
17
140
1.22
0.27
1.2
1.1
—
—
—
0
0
(44790049)
16
131
1.22
0.27
1.3
1.5
—
—
—
0
0
(44790047)
16
131
1.22
0.27
1.3
1.5
—
—
—
0
0
(44790048)
16
131
1.22
0.27
1.3
1.5
—
—
—
0
0
(44806118)
16
131
1.22
0.27
1.3
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
32
281
1.14
0.26
2.6
3.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
33
291
1.14
0.26
1.8
1.8
iu/l
2.9
4.9
1.25
11
95
(1616796) Gas panel - Central venous blood
28
244
1.15
0.26
2.4
3.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
18
151
1.19
0.25
1.2
1.0
u/ml
0.7
2.6
—
5
64
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
10
78
1.28
0.24
1.7
1.4
u/l
16.0
14.0
—
10
73
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
26
228
1.14
0.22
2.0
1.8
nmol/l
47.8
41.4
0.63
26
216
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
10
79
1.27
0.22
1.0
1.0
ng/l
608.0
633.9
—
5
48
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
106
1002
1.06
0.22
3.7
3.5
mmol/l
1.2
1.2
0.31
94
854
(3037556) Urate [Mass/volume] in Serum or Plasma
5
41
1.22
0.22
1.8
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
41
1.22
0.22
1.2
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.0
—
17.2
—
0
11
(4212803)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.0
—
10.8
—
0
5
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
80
750
1.07
0.21
1.4
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
188
0.85
0.21
2.4
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.3
—
8.7
—
0
5
(3009015) Lactate [Moles/volume] in Synovial fluid
0
13
0.00
0.21
0.0
1.2
—
6.9
—
0
8
(40768806) Pleura Pathology biopsy report
11
134
0.82
0.20
1.4
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
38
346
1.10
0.19
5.9
5.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
90
1.22
0.19
1.0
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
14
164
0.85
0.18
1.6
1.5
g/l
27.8
31.0
0.52
14
145
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
100
1.20
0.18
2.3
2.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
141
0.85
0.16
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
141
0.85
0.16
1.2
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
149
1.14
0.15
1.4
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
32
293
1.09
0.15
1.7
2.4
ug/min
44.7
75.0
0.68
18
177
(3025130) Human papilloma virus identified in Specimen
10
119
0.84
0.15
1.3
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
93
971
0.95
0.14
5.0
4.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
14
122
1.15
0.13
1.9
2.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
180
1.11
0.13
1.4
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
104
1.16
0.12
1.2
2.1
—
—
—
0
0
(4035726)
106
1026
1.04
0.11
1.5
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
13
145
0.90
0.09
1.5
1.4
e6/l
1034.1
1606.6
—
8
100
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
145
0.90
0.09
1.4
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
217
0.92
0.09
2.8
3.7
e9/l
3.7
4.3
1.07
20
217
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
124
0.89
0.09
1.1
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
55
1.09
0.09
11.8
6.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
58
1.03
0.08
1.3
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
149
1459
1.02
0.08
8.7
7.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
5
63
0.79
0.08
1.0
1.9
mmol/l
9.5
9.6
—
5
51
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
64
1.09
0.08
9.4
3.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
70
0.86
0.07
1.2
2.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
314
1.05
0.07
1.8
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
305
0.95
0.06
1.3
1.5
—
—
—
0
0
(4034850)
37
356
1.04
0.05
9.8
11.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
100
1.10
0.05
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
22
209
1.05
0.04
3.1
2.7
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
12
111
1.08
0.04
1.2
1.3
u/l
196.9
279.8
0.82
12
106
(3050129) First trimester maternal screen panel - Serum or Plasma
21
200
1.05
0.03
1.2
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
34
351
0.97
0.03
1.1
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
32
310
1.03
0.03
1.3
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
112
1.07
0.03
1.5
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
168
0.95
0.02
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
168
0.95
0.02
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
168
0.95
0.02
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
168
0.95
0.02
1.3
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
172
1.05
0.02
1.4
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
22
216
1.02
0.00
1.9
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
224
0.98
0.00
2.8
4.0
%
56.8
58.3
0.19
22
224
(3032773) Endomysium IgG Ab [Titer] in Serum
10
98
1.02
0.00
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
102
0.98
0.00
1.0
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
12
122
0.98
0.00
1.7
1.4
mmol/l
7.7
6.8
0.51
12
112
(3012441) Differential panel - Pleural fluid
12
122
0.98
0.00
1.4
1.4
—
—
—
0
0
(4281824)
14
142
0.99
0.00
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
152
0.99
0.00
1.2
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
109
1.01
0.00
1.4
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
157
1.02
0.00
1.1
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
34
345
0.99
0.00
1.4
1.6
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
2.6
—
1.4
—
0
7
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
6
59
1.02
0.00
1.8
2.6
e6/l
404.5
902.1
—
6
48
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
13.6
—
0
6
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
52
0.96
0.00
1.2
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
59
0.85
0.00
2.0
1.7
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
0
5
0.00
0.00
0.0
1.2
—
1.0
—
0
5
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
7
0.00
0.00
0.0
3.4
—
15.7
—
0
7
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
33.7
—
0
6
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
8
83
0.96
0.00
1.4
1.2
u/l
6.1
11.6
—
8
75
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
94
0.96
0.00
1.1
1.6
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
16.0
—
126.0
—
0
5
(3025315) Body weight
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
272.2
—
0
5
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
59
1.02
0.00
1.3
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
7
72
0.97
0.00
1.0
1.6
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_VESTIFUNCNAS and mortality.

Females

Parameter HR [95% CI] p-value
H8_VESTIFUNCNAS 1.017 [0.9, 1.14] 0.778
Birth year 0.994 [0.99, 1.0] 0.148

During the follow-up period (1.1.1998 — 31.12.2019), 998 out of 4177 females with H8_VESTIFUNCNAS died.

Males

Parameter HR [95% CI] p-value
H8_VESTIFUNCNAS 1.072 [0.92, 1.25] 0.379
Birth year 0.988 [0.98, 1.0] 0.018

During the follow-up period (1.1.1998 — 31.12.2019), 515 out of 2384 males with H8_VESTIFUNCNAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_VESTIFUNCNAS.

N-year risk Females Males
1 0.075% 0.234%
5 0.553% 1.328%
10 1.479% 3.317%
15 2.903% 6.326%
20 4.988% 10.675%

Relationships between endpoints

↥

Index endpoint: H8_VESTIFUNCNAS – Other/unspecified disorders of vestibular function

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data